Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 7Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stomach Neoplasms 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Nervous System Neoplasms 1

Interventions

Filgrastim 12Carboplatin 10Ifosfamide 9Peripheral Blood Stem Cell Transplantation 8Paclitaxel 8Etoposide 7Cyclophosphamide 4Thiotepa 3Flow Cytometry 3Cisplatin 3sargramostim 2pegfilgrastim 2etoposide phosphate 2aldesleukin 2Temozolomide 2Microarray Analysis 2Methylprednisolone 2Immunologic Techniques 2Gemcitabine 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2tislelizumab 1milademetan 1ixabepilone 1dexamethasone acetate 1dexamethasone 21-phosphate 1Topotecan 1Tacrolimus 1Sunitinib 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Germ Cell Tumor × Sunitinib × Gynecologic × Clear all
NCT00453310 2015-10-27

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
10 enrolled 6 charts
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡